A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Phase 3 Study of Dexpramipexole in ALS (EMPOWER)
http://clinicaltrials.gov/ct2/show/NCT01281189
Çalışma devam ediyor, hasta kaydı kabul edilmiyor.
Hiç yorum yok:
Yorum Gönder